the author describes the notions that led to initiation of controlled trials of long-term medication with antiarrhythmic drugs following myocardial infarction , and reviews reports of controlled trials with diphenylhydantoin , alprenolol , and procaine amide .
C0003195
antiarrhythmic drugs
C0033216
procaine amide